generic of semaglutide Canada approves from Dr. Reddy's, a G7 first enabled by Novo Nordisk's lapsed CAD$250 patent Availability of generic semaglutide removes

Turmerics rise in the wellness world might feel recent, but its roots go back thousands of years

Expert Consensus: American College of Physicians: GLP-1 receptor agonists should be considered for patients with obesity who have not achieved weight loss goals with lifestyle modifications. Endocrine Society: Semaglutide and tirzepatide represent significant advances in obesity pharmacotherapy and should be considered first-line options. Obesity Medicine Association: The dramatic efficacy of GLP-1 and dual agonist medications has fundamentally changed the treatment landscape for obesity. Real-World Effectiveness: Studies of patients using these medications outside clinical trials show: GLP-1s: Similar to clinical trial results (confirming real-world effectiveness) Older medications: Often less effective in real-world than trials (adherence issues) Patient satisfaction: Highest with GLP-1s Bottom Line: Which Works Best

In this article, we'll walk you through the different types of weight loss medications, how they work, their benefits and risks, and how they fit into an overall weight reduction strategy

Though moderate drinking while on semaglutide and related drugs likely isnt dangerous, it could make it harder for some people to achieve the weight loss they desire

Funnel plot for the studies that were included in the meta-analysis of the risk of any cancer in tirzepatide versus pooled control groups